Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cell therapy
Biotech
FDA rejects Capricor’s DMD cell therapy, asks for more data
The rejection raises questions about whether the new-look FDA leadership may be rowing back from some of the flexibility shown by the old regime.
Nick Paul Taylor
Jul 11, 2025 9:18am
Minovia skates SPAC-wards into public market
Jun 25, 2025 10:33am
Industry disappointed as FDA reportedly puts Verdun on leave
Jun 20, 2025 1:53am
Fierce Pharma
BioNTech to wind down cell therapy manufacturing in Maryland
Jun 18, 2025 10:23am
As investors pivot from cell therapy, Immatics keeps the faith
Jun 6, 2025 3:50am
ASCO: Immatics cell therapy sees 56% ORR in advanced melanoma
May 31, 2025 8:00am